Impact of statin treatment on non-invasive tests based predictions of fibrosis in a referral pathway for NAFLD.

Mustafa Al-KaraghouliSonia FuentesTracy DavydukeMang MaJuan G Abraldes

Published in: BMJ open gastroenterology (2022)

In patients with NAFLD referred from PC, those on statins had higher chances of a high VCTE for a given FIB-4 value, but this had a negligible impact on the NPV of the commonly used FIB-4 threshold (<1.3).

Keyphrases

liver fibrosis
cardiovascular disease
primary care
type diabetes
replacement therapy